Literature DB >> 7166487

Sjögren-Larsson syndrome: physical and neurological features. A survey of 35 patients.

S Jagell, J Heijbel.   

Abstract

Sjögren-Larsson syndrome (SLS) is characterized by congenital ichthyosis, mental retardation and spastic di- or tetraplegia. All patients older than one year have glistening dots in the fundus of the eye. SLS has autosomal recessive inheritance. All 35 SLS patients in Sweden, alive in 1978, were examined physically and neurologically by the authors. Prematurity was common but did not have any prognostic importance. Thirty-two patients had non-progressive pronounced or severe spastic diplegia, and two had severe tetraplegia. Those who were most motor-handicapped were also most mentally retarded. However, the degree of ichthyosis and the changes in the ocular fundus varied independently of the cerebral symptoms. There were no morphological abnormalities of the brain found in cranial computed tomography. Shortness of stature was due to poor development of paretic legs and contractures in joints and the spine due to spasticity. SLS should be suspected in a child with congenital ichthyosis. The diagnosis is confirmed when signs of spasticity and mental retardation are present before the age of three years.

Entities:  

Mesh:

Year:  1982        PMID: 7166487

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  11 in total

1.  Carrier detection for Sjögren-Larsson syndrome.

Authors:  T L Kelson; D A Craft; W B Rizzo
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Sjogren - Larsson Syndrome.

Authors:  A K Dubey; R K Gupta; Arvind Gupta
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.

Authors:  W B Rizzo; G Carney; Z Lin
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 4.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

5.  Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.

Authors:  Kathleen Davis; Kenton R Holden; Dana S'Aulis; Claudia Amador; M Gisele Matheus; William B Rizzo
Journal:  J Child Neurol       Date:  2012-10-03       Impact factor: 1.987

6.  Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

Authors:  Ujjawal Roy; Urmila Das; Alak Pandit; Anjan Debnath
Journal:  BMJ Case Rep       Date:  2016-04-19

7.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

8.  Cranial CT in the Sjogren-Larsson syndrome.

Authors:  L J Mulder; A P Oranje; M C Loonen
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

9.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

10.  A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

Authors:  Simone Warrack; Terri Love; William B Rizzo
Journal:  J Child Neurol       Date:  2021-07-28       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.